Sep 05, 2024 This annual virtual event dedicated to biomaterials and material science for 3D printing implants, medical devices, and biofabrication presents a unique and compelling opportunity for individuals across various disciplines to delve into the cutting-edge advancements shaping the future of healthcare. With the demand for innovative solutions in implantology and tissue engineering on the rise, this event serves as a pivotal platform for researchers, engineers, clinicians, entrepreneurs, and industry professionals to explore the latest breakthroughs and methodologies in biomaterials science. Attendees will have the chance to gain invaluable insights into the development of novel materials, fabrication techniques, and biofunctionalization strategies tailored for applications in 3D printing implants, medical devices, and biofabrication. From elucidating the fundamental properties of biomaterials to showcasing innovative approaches for enhancing biocompatibility, mechanical properties, and bioactivity of implants, this event offers a comprehensive overview of the current state-of-the-art in material science for medical applications. Moreover, the virtual format ensures accessibility to a global audience, facilitating networking opportunities and knowledge exchange among professionals from diverse backgrounds and regions.
Apply to speak or sponsor the event: info@3dheals.com
Subscribe here to receive event emails.
Speakers:
Rao Bezwada
An accomplished scientist and entrepreneur, Rao S. Bezwada, Ph.D. established Bezwada Biomedical, an innovation-based and technology-driven research company, in 2003. The company is focused on developing a wide range of novel absorbable polymeric biomaterials to enhance quality of life by producing next generation bioabsorbable medical devices with therapeutic applications. Dr. Bezwada earned a doctorate in chemistry from the Stevens Institute of Technology in New Jersey and has over 40 years of research experience in the medical device industry, including 20 years of service at Ethicon, Inc. (a Johnson & Johnson Company). While at Ethicon, Dr. Bezwada’s research and development efforts led to the launch of a number of products, including Monocryl®, a new ultra-pliable synthetic absorbable monofilament suture. This product has represented worldwide sales of more than two (2) billion dollars since its launch in 1993 and current annual sales of over 100 million dollars. In recognition of this invention, along with its development, Johnson & Johnson, Inc. awarded Dr. Bezwada the prestigious Johnson Medal in 1996. Dr. Bezwada has been a prolific inventor and has been issued more than 135 U.S. patents on absorbable polyurethanes, absorbable amino acid polymers, absorbable polyester amides, absorbable polyoxaesters, and controlled release polymers. FDA-approved products such as MONTAGE® Putty, MONTAGE Fast Set Putty, Montage Flowable Putty, and PERMATAGE Putty, marketed by Abyrx for wound healing and bone applications, are based on Bezwada Biomedical’s absorbable polyurethane technology. Dr. Bezwada has also pioneered specialty bio-inks for 3D printing applications. In addition to his passion for science and technical accomplishments, Dr. Bezwada has also established a non-profit organization, Society for Basic Needs, in India. This organization has a mission aimed at improving the quality of life for those less fortunate by providing them with essential amenities and opportunities for health and education.
Mohammad Albanna, PhD
Dr. Albanna is the founder and CEO of Humabiologics, one of the only regenerative medicine companies focused on developing and commercializing human-derived biomaterials to researchers around the world for regenerative medicine applications. He holds a PhD in Biomedical Engineering, 2 master’s degrees in Materials Sciences and Electrical & Computer Engineering and completed a postdoctoral fellowship at Wake Forest Institute of Regenerative Medicine, where he served as the lead of the skin bioprinting group and is currently an adjunct assistant professor of Surgery at Atrium Health Wake Forest Baptist. Dr. Albanna authored several peer-reviewed papers, book chapters and is the inventor of several issued and patent-pending applications. Dr. Albanna has 15 years of industry experience, during which he has held several senior and executive leadership positions across several industries including medical devices, blood banking, and tissue banking. His work in regenerative medicine was recognized through several prestigious awards including 2013 Thomas Edison Gold Award in Innovation, 2018 Arizona Innovator of the year finalist, and 2021 Arizona Leader in Innovation Award.
Anis Hadj Henni
As CEO, Anis Hadj Henni oversees Rheolution’s development strategy over the Life Sciences and Agri-Food business units. He is also in charge of the customer experience and key partnerships with strategic business partners, distributors and investors. Anis works closely with Rheolution’s sales, operations and engineering teams to provide the best instruments, software and services to customers. As an entrepreneur, Anis is driven by a powerful purpose: ‘‘My team and I are on the mission of ending the status quo in the analytical testing space that limits our customer’s ability to innovate and create value for the benefit of people’s health and nutrition. We are defining, with our community of users, Soft Matter Analytics as the paradigm that will shape the future of analytical instrumentation. And, because an idea is not enough, we gathered an outstanding and talented team that works hard to make Soft Matter Analytics a realty to our customers and communities’’, he says. After a successful career in research, Anis co-founded Rheolution in 2009 with new ideas and a vision of what the future could look like. A decade after, he is extremely proud of seeing customers, colleagues, business partners and stakeholders sharing, enriching and building that vision. Anis graduated in civil engineering from the National Polytechnic School of Algiers (Algeria) and holds a Ph.D. in mechanics from Université de Bordeaux (France).
Annaliese Vojnich
Meet Annaliese Vojnich, a dynamic business development and technical sales manager currently overseeing the Puredyne® brand and the Hygienic Solutions division for ViscoTec America. Annaliese’s professional journey spans various industries, including sales, pharmaceuticals, medical technology, research and development, and hygienic FDA manufacturing, equipping her with a versatile skill set that stands at the forefront. Earning a bachelor’s degree in Dietetics/Nutritional Sciences from the esteemed University of Georgia in 2018, Annaliese’s academic foundation underscores her commitment to knowledge and growth. Her pursuit of education extended further with a Certificate in Women’s Entrepreneurship from Cornell University, where she refined her leadership abilities in 2022. Annaliese’s passion for biotechnology began in 2014 at the Center for Applied Genetic Technologies, a University of Georgia facility. During her time as an assistant lab manager and research assistant, her responsibilities were concentrated on genetic transformation, somatic embryogenesis, plant breeding and genetics, and tissue culture management. Annaliese’s foundation has positioned her to excel not only in sales and management roles but also in bridging the gap between innovation and real-world applications. Her current role at ViscoTec America, where she contributes to cutting-edge dosing technology and bioprinting advancements, showcases her ability to merge her passion for science with her sales acumen.
Ferry Melchels
Ferry Melchels is the research professor of Biomaterials and Tissue Engineering at the Future Industries Institute at the University of South Australia in Adelaide. His main interests lie in polymeric biomaterials for 3D printing, tissue engineering, and drug and vaccine delivery. His work has been published in leading journals, attracting over 17,000 citations. He is a recipient of the Patrick Neill Medal for Early Career Researchers in the Life Sciences from the Royal Society of Edinburgh (2020), and the Mid-Career Investigator Award from the International Society for Biofabrication (2019). Ferry holds an MSc (2005) in chemical engineering and PhD (2010) in biomaterials from the University of Twente (The Netherlands). He was a Marie Curie post-doctoral fellow between two of the pioneering institutes in Biofabrication; Queensland University of Technology (Brisbane, Australia) and University Medical Center Utrecht (The Netherlands) and held his first PI position at Heriot-Watt University in Edinburgh (UK) from 2015-2023. Besides home brewing the best beers on the weekend, his future aim is to continue advancing materials-based technology platforms for biomedical applications.
Moderator:
Dr. Jenny Chen
Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.
Now on Demand:
Subscribe here to receive event emails.
Thanks to Our Sponsors:
Comments